# A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure Monitoring

> **NCT00618956** · PHASE3 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 321 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** Milnacipran hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00618956
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-07
- **Final completion:** —
- **Target enrollment:** 321 (ACTUAL)
- **Last updated:** 2009-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00618956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00618956, "A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure Monitoring". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00618956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*